Options traders are showing renewed interest in a leading pharmaceutical stock, signaling possible bullish sentiment ahead of key market developments.
- Options traders are focusing on a major pharmaceutical stock.
- The healthcare sector is attracting attention amid market uncertainty.
- Pfizer (PFE) and Johnson & Johnson (JNJ) are among the names under scrutiny.
- Options volume suggests potential positioning for future catalysts.
- The S&P 500 (^SPX) shows mixed performance in the sector.
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.